Symbols

IRMD

Iradimed·NASDAQ

--(--)

7.89 / 10

Outperform

No analyst consensus is available; the CEO sold 5,000 shares at $101.38, a minor bearish signal. Fund‑flow score is 7.89 (good) with overall, block, small and large inflow ratios above 0.5 and positive trends, offset by medium and extra‑large weakness.

Fund Flow Rating

What is the market sentiment for IRMD?

IRMD holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.89/10 (Outperform).